This latest study reveals that #CUDC907 & #temozolomide synergistically suppress GBM progression, with CUDC-907 reducing resistance by inhibiting #DNAdamage repair mechanisms, promising novel #therapeutic avenues for GBM. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...